The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $37.55

Today's change-0.14 -0.37%
Updated December 7 4:02 PM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $37.55

Today's change-0.14 -0.37%
Updated December 7 4:02 PM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.14

GlaxoSmithKline PLC closed lower Wednesday, dropping (U.S.)$0.14 or 0.37% to (U.S.)$37.55. Over the last five days, shares have lost 0.64% and are down 6.94% for the last year to date. This security has underperformed the S&P 500 by 14.03% during the last year.

Key company metrics

  • Open(U.S.) $37.47
  • Previous close(U.S.) $37.69
  • High(U.S.) $37.63
  • Low(U.S.) $37.20
  • Bid / Ask-- / --
  • YTD % change-6.94%
  • Volume4,975,806
  • Average volume (10-day)4,034,618
  • Average volume (1-month)4,563,956
  • Average volume (3-month)3,261,560
  • 52-week range(U.S.) $37.20 to (U.S.) $45.58
  • Beta0.89
  • Trailing P/E247.04×
  • P/E 1 year forward14.63×
  • Forward PEG1.25×
  • Indicated annual dividend(U.S.) $2.09
  • Dividend yield5.56%
  • Trailing EPS(U.S.) $0.15
Updated December 7 4:02 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue7,5426,5326,2296,286
Total other revenue--------
Total revenue7,5426,5326,2296,286
Gross profit5,0994,4764,1594,082
Total cost of revenue2,4432,0562,0702,204
Total operating expense6,1116,6835,5066,539
Selling / general / administrative2,2322,0752,0762,122
Research & development876800775846
Depreciation / amortization11101010
Interest expense (income), net operating--------
Unusual expense (income)6561,825666910
Other operating expenses, total-107-83-91447
Operating income1,431-151723-253
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,274-318560-416
Income after tax885-492352-428
Income tax, total38917420812
Net income808-435282-354
Total adjustments to net income--------
Net income before extra. items808-435282-354
Minority interest-7757-7074
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items808-435282-354
Inc. avail. to common incl. extra. items808-435282-354
Diluted net income809-435282-354
Dilution adjustment1--00
Diluted weighted average shares4,9024,8594,8904,837
Diluted EPS excluding extraordinary itemsvalue per share0.17-0.090.06-0.07
Dividends per sharevalue per share0.190.190.190.23
Diluted normalized EPSvalue per share0.260.150.140.05